Maricar Malinis

3.3k total citations
86 papers, 854 citations indexed

About

Maricar Malinis is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Maricar Malinis has authored 86 papers receiving a total of 854 indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Infectious Diseases, 47 papers in Epidemiology and 9 papers in Surgery. Recurrent topics in Maricar Malinis's work include Pneumocystis jirovecii pneumonia detection and treatment (18 papers), Antifungal resistance and susceptibility (15 papers) and COVID-19 Clinical Research Studies (11 papers). Maricar Malinis is often cited by papers focused on Pneumocystis jirovecii pneumonia detection and treatment (18 papers), Antifungal resistance and susceptibility (15 papers) and COVID-19 Clinical Research Studies (11 papers). Maricar Malinis collaborates with scholars based in United States, Italy and Argentina. Maricar Malinis's co-authors include Marwan M. Azar, Helen W. Boucher, Elizabeth Cohen, Jeffrey Topal, Alan Koff, Robin K. Avery, Roland Assi, Nabin K. Shrestha, Allison E. Aiello and Dayna McManus and has published in prestigious journals such as New England Journal of Medicine, JAMA and Blood.

In The Last Decade

Maricar Malinis

77 papers receiving 835 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maricar Malinis United States 15 447 431 140 111 107 86 854
Ricardo M. La Hoz United States 16 437 1.0× 348 0.8× 131 0.9× 128 1.2× 125 1.2× 57 817
Elena Beam United States 14 452 1.0× 266 0.6× 260 1.9× 101 0.9× 85 0.8× 67 873
Yoichiro Natori United States 13 281 0.6× 461 1.1× 133 0.9× 79 0.7× 164 1.5× 54 804
Eugene Katchman Israel 12 294 0.7× 605 1.4× 60 0.4× 41 0.4× 48 0.4× 22 886
Jackrapong Bruminhent Thailand 15 384 0.9× 307 0.7× 93 0.7× 73 0.7× 71 0.7× 69 679
Jordí Niubó Spain 19 540 1.2× 446 1.0× 41 0.3× 49 0.4× 205 1.9× 70 1.2k
Edward A. Dominguez United States 12 893 2.0× 537 1.2× 94 0.7× 89 0.8× 116 1.1× 21 1.1k
Chris Taylor United Kingdom 17 559 1.3× 549 1.3× 210 1.5× 49 0.4× 53 0.5× 49 1.2k
Ingi Lee United States 14 358 0.8× 317 0.7× 227 1.6× 96 0.9× 60 0.6× 23 851
Maria Teresa Seville United States 16 402 0.9× 621 1.4× 101 0.7× 10 0.1× 60 0.6× 53 949

Countries citing papers authored by Maricar Malinis

Since Specialization
Citations

This map shows the geographic impact of Maricar Malinis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maricar Malinis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maricar Malinis more than expected).

Fields of papers citing papers by Maricar Malinis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maricar Malinis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maricar Malinis. The network helps show where Maricar Malinis may publish in the future.

Co-authorship network of co-authors of Maricar Malinis

This figure shows the co-authorship network connecting the top 25 collaborators of Maricar Malinis. A scholar is included among the top collaborators of Maricar Malinis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maricar Malinis. Maricar Malinis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Malinis, Maricar, G. Gan, Muneer H. Abidi, et al.. (2025). Frailty by Chart Review Can Predict Infection in Kidney Transplant Recipients: A Multicenter Study through the AST IDCOP. American Journal of Transplantation. 25(8). S163–S163. 1 indexed citations
2.
Koff, Alan & Maricar Malinis. (2025). Bacterial Infections Involving the Liver. Clinics in Liver Disease. 29(3). 431–452.
3.
Kumar, Rebecca N., et al.. (2024). The pre‐transplant evaluation: Considerations for trainees and early career transplant infectious diseases clinician. Transplant Infectious Disease. 26(4). e14326–e14326.
4.
Durand, Christine M., Mary G. Bowring, Jonathan Hand, et al.. (2024). Influence of induction therapy and antiretroviral regimen on outcomes in kidney transplant recipients living with human immunodeficiency. Transplant Infectious Disease. 26(4). e14287–e14287. 1 indexed citations
5.
Hunter, Cameron J., Jan Philipp Bewersdorf, Lourdes Mendez, et al.. (2024). Toxicity and Efficacy of Isavuconazole Vs Voriconazole As Anti-Fungal Prophylaxis for Patients with Acute Myeloid Leukemia. Blood. 144(Supplement 1). 1480–1480. 1 indexed citations
6.
Mullis, Caroline E., Madeleine R. Heldman, Nathan C. Bahr, et al.. (2024). Persistent fever after coronavirus disease 2019 in liver/kidney transplant recipient. Transplant Infectious Disease. 26(3). e14271–e14271.
7.
8.
Shipper, Andrea Goldstein, et al.. (2024). A Scoping Review of Arthropod‐Borne Flavivirus Infections in Solid Organ Transplant Recipients. Transplant Infectious Disease. 26(6). e14400–e14400.
9.
Azar, Marwan M., et al.. (2022). Real-world experience with available, outpatient COVID-19 therapies in solid organ transplant recipients during the omicron surge. American Journal of Transplantation. 22(10). 2458–2463. 59 indexed citations
10.
Cohen, Elizabeth, et al.. (2022). The cascade of care in testing and treatment of latent tuberculosis infection in liver transplant candidates. Transplant Infectious Disease. 25(1). e13999–e13999. 1 indexed citations
11.
Azar, Marwan M., et al.. (2022). Evaluating clinical effectiveness of SARS‐CoV‐2 vaccine in solid organ transplant recipients: A propensity score matched analysis. Transplant Infectious Disease. 24(4). e13876–e13876. 8 indexed citations
12.
Roberts, Scott C., Nathan D. Grubaugh, Tara Alpert, et al.. (2021). An outbreak of SARS‐CoV‐2 on a transplant unit in the early vaccination era. Transplant Infectious Disease. 24(2). e13782–e13782. 5 indexed citations
13.
Marcelin, Jasmine R, Nicolás Cortés-Penfield, Carlos del Rı́o, et al.. (2021). How the Field of Infectious Diseases Can Leverage Digital Strategy and Social Media Use During a Pandemic. Open Forum Infectious Diseases. 8(2). ofab027–ofab027. 13 indexed citations
14.
Holowka, Thomas, Maricar Malinis, Geliang Gan, et al.. (2021). Incidence and associated risk factors for invasive fungal infections and other serious infections in patients on ibrutinib. Journal of Infection and Chemotherapy. 27(12). 1700–1705. 9 indexed citations
15.
Park, Jakob, et al.. (2021). Multimodality Imaging in the Diagnosis of Prosthetic Valve Endocarditis: A Brief Review. Frontiers in Cardiovascular Medicine. 8. 750573–750573. 11 indexed citations
16.
17.
Azar, Marwan M., et al.. (2016). DisseminatedMycobacterium tuberculosisfollowing renal transplant with alemtuzumab induction. BMJ Case Reports. 2016. bcr2016217998–bcr2016217998. 3 indexed citations
18.
Sack, Jordan, David R. Peaper, Pramod K. Mistry, & Maricar Malinis. (2016). Clinical implications of Paracoccus yeeii bacteremia in a patient with decompensated cirrhosis. IDCases. 7. 9–10. 6 indexed citations
19.
Malinis, Maricar. (2009). Clinical Outcomes of HIV-Infected Patients Hospitalized with Community-Acquired Pneumonia: Results from CAPO International Cohort Study.
20.
Aiello, Allison E., Maricar Malinis, Jennifer K. Knapp, & Lona Mody. (2008). The influence of knowledge, perceptions, and beliefs, on hand hygiene practices in nursing homes. American Journal of Infection Control. 37(2). 164–167. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ricardo M. La Hoz Breakdown of academic impact, for papers by Elena Beam Breakdown of academic impact, for papers by Yoichiro Natori Breakdown of academic impact, for papers by Eugene Katchman Breakdown of academic impact, for papers by Jackrapong Bruminhent Breakdown of academic impact, for papers by Jordí Niubó Breakdown of academic impact, for papers by Edward A. Dominguez Breakdown of academic impact, for papers by Chris Taylor Breakdown of academic impact, for papers by Ingi Lee Breakdown of academic impact, for papers by Maria Teresa Seville
Rankless by CCL
2026